FDA Approves Xyzal For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
Links shared publicly online about this topic.
- 1,796total visits
FDA Approves Xyzal For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
Xyzal (levocetirizine) is used to treat perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies). Includes Xyzal side effects, interactions and indications.
View full resource at drugs.com
Tags: Seasonal Allergy, Allergy Medication, Antihistamine, Indoor Allergy, Urticaria, Children's Health, FDA, Xyzal
Most Recently Shared on August 26, 2009 at 12:18 am By:
FDA Approves Xyzal For Use In Children Age Six Months And Older - http://bit.ly/pSsS2
Advertisement
